Dronedarone-current status in management of atrial fibrillation.

Indian Heart Journal
Gajendra Manakshe, B Hygriv Rao

Abstract

Atrial fibrillation (AF) is the most common of the serious cardiac rhythm disturbances and is responsible for substantial morbidity and mortality. Available drug therapy for AF has modest efficacy and is associated with the risk of life-threatening pro-arrhythmic complications. Dronedarone is a newer therapeutic agent with a structural resemblance to amiodarone and a better side effect profile. It is a multichannel blocker with antiadrenergic properties and has been evaluated in both rate and rhythm control strategies in the management of AF. In this review, we discuss the current role of dronedarone in the contemporary management of AF.

References

Aug 1, 1991·Stroke; a Journal of Cerebral Circulation·P A WolfW B Kannel
Sep 9, 2000·The New England Journal of Medicine·A Aggarwal
Jan 28, 2003·Journal of Cardiovascular Pharmacology·Patrick GautierDino Nisato
Aug 2, 2003·Journal of Cardiovascular Electrophysiology·Nathalie LalevéeSylvain Richard
Aug 16, 2003·European Heart Journal·Paul TouboulStefan H Hohnloser
Jan 24, 2006·Lancet·Stanley Nattel, Lionel H Opie
May 13, 2006·Current Problems in Cardiology·Michael J Riley, Nassir F Marrouche
Dec 2, 2006·Nature Reviews. Drug Discovery·Stanley Nattel, Leif Carlsson
Aug 30, 2008·Clinical Endocrinology·T S HanM P J Vanderpump
Nov 10, 2010·Circulation Journal : Official Journal of the Japanese Circulation Society·Sébastien KnechtMichel Haïssaguerre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Related Papers

Vascular Health and Risk Management
Pawan D PatelRohit R Arora
Expert Review of Cardiovascular Therapy
Michele Marzocchi, Federico Lombardi
Heart Rhythm : the Official Journal of the Heart Rhythm Society
David S Park, Gregory E Morley
© 2021 Meta ULC. All rights reserved